| P/E (FY) | 5.0 | Sales (TTM) | $48.3M |
| Earnings (TTM) | -$1.7M | ROE | 4.09% |
| Net Margin | 1.49% | ROIC | 4.62% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | −37.00% | Sales Growth 3Y | −1.13% |
| Market Cap | $4.7M | Trading Days | 2102 |
| 52W High | 0.42 |
| 52W Low | 0.15 |
| % Off High | −64.21% |
| YTD | −58.25% | 1Y | −48.17% |
| 3Y | −53.03% | 5Y | −85.95% |
| 10Y | 275.75% | Since incept. (ann.) | 2.70% |
Contract Manufacturing 95% · Other Nutraceutical Business 5%
| Ann. Volatility (1Y) | 67.23% | Ann. Volatility (3Y) | 81.82% |
| Sharpe (1Y) | −0.66 | Sharpe (3Y) | 0.08 |
| Max Drawdown (1Y) | −60.53% | Max Drawdown (3Y) | −62.50% |
| Beta (3Y, vs SPY) | 0.30 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| RNAZ | Transcode Therapeutics, Inc. | $4.8M | — |
| ENVB | Enveric Biosciences, Inc. | $4.9M | — |
| DRMA | Dermata Therapeutics, Inc. | $5.0M | — |
| ELAB | PMGC Holdings Inc. | $4.3M | — |
| APVO | Aptevo Therapeutics Inc. | $5.2M | — |
| CVSI | CV Sciences, Inc. | $4.1M | — |
| GOVX | GeoVax Labs, Inc. | $5.4M | — |
| SNGX | SOLIGENIX, INC. | $5.4M | — |
| REVB | REVELATION BIOSCIENCES, INC. | $4.1M | — |
| LIANY | LianBio | $5.4M | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | $4.0M |
| — |
| JUNS | JUPITER NEUROSCIENCES, INC. | $4.0M | — |
